Court's rul­ing on Il­lu­mi­na-Grail deal could sig­nal a lim­it to Eu­ro­pean an­titrust pow­ers

9 months ago
Deals
Pharma

Pfiz­er and Val­ne­va say sec­ond Ly­me boost­er led to 'strong' re­spons­es, tar­get 2026 FDA sub­mis­sion

9 months ago
Pharma

Dana-Far­ber chief Lau­rie Glim­ch­er set to leave sto­ried can­cer cen­ter

9 months ago
People

Eu­ro­pean Com­mis­sion re­vokes Ocali­va's au­tho­riza­tion ahead of FDA ad­comm

9 months ago
Pharma
FDA+

Three Dyne ex­ec­u­tives leave as com­pa­ny re­ports new Duchenne drug da­ta

9 months ago
People
R&D

No­vo Nordisk con­tin­ues to grap­ple with patchy GLP-1 drug sup­ply in Eu­rope

9 months ago
Pharma
Manufacturing

Prax­is' epilep­sy drug re­duces seizures by 46% in pe­di­atric pa­tients in Phase 2 study

9 months ago
R&D

De­nali de­tails ac­cel­er­at­ed ap­proval plans; Jaz­z's $850M pri­vate of­fer­ing

9 months ago
News Briefing

ProKid­ney ax­es one Phase 3 study, aims for 'ex­pe­dit­ed ap­proval path­way' us­ing an­oth­er

9 months ago
R&D

With few specifics, Re­cur­sion un­der­whelms with first Phase 2 read­out, but ‘plans to ad­vance’ drug

9 months ago
R&D
AI

Ex­clu­sive: Pa­tient­Part­ner rais­es $7M to help phar­ma com­pa­nies match pa­tients with men­tors

9 months ago
Health Tech

Up­dat­ed: Vax­cyte surges on Phase 1/2 da­ta for 31-va­lent pneu­mo­coc­cal vac­cine

9 months ago
R&D

Ex­clu­sive: Duke spin­out launch­es in hopes of pre­vail­ing with brain can­cer bis­pe­cif­ic where Am­gen, Roche did not

9 months ago
Startups
R&D

Ar­row­head spot­lights key pan­cre­ati­tis fig­ures from Phase 3 lipid dis­ease study to dif­fer­en­ti­ate it­self from Io­n­is

9 months ago
R&D

Sanofi’s BTK in­hibitor goes 1-for-3 in key MS tri­als, slows dis­abil­i­ty pro­gres­sion

9 months ago
R&D
Pharma

Bay­er’s Keren­dia cuts heart death, fail­ure and hos­pi­tal­iza­tion by 16% in Phase 3 tri­al

9 months ago
R&D
Pharma

FDA au­tho­rizes No­vavax Covid boost­er; Re­cur­sion nears key da­ta read­outs; What’s next for CD47?; and more

9 months ago
Weekly

FDA au­tho­rizes No­vavax's up­dat­ed Covid boost­er

9 months ago
Pharma
FDA+

No­vo Nordisk re­veals post-hoc car­dio­vas­cu­lar da­ta for semaglu­tide

9 months ago
Pharma

Biose­cure vote slat­ed for Sep­tem­ber

9 months ago
China
FDA+

Ipsen sells pri­or­i­ty re­view vouch­er for high­est price since 2016

9 months ago
Pharma
FDA+

FDA ap­proves Emer­gent vac­cine for mpox as com­pa­ny plans to do­nate 50,000 dos­es

9 months ago
Pharma
FDA+

Mer­ck opens Lon­don lab as it makes push in­to im­munol­o­gy and the UK

9 months ago
R&D
Pharma

Ja­co­bio's Chi­na rights deal; Reneu­ron off the Lon­don ex­change

9 months ago
News Briefing
First page Previous page 110111112113114115116 Next page Last page
A service from the Financial Times